Anthropic’s Claude Science is presented as an AI workbench for scientific work, but the product people described is much narrower and more concrete than the name suggests. It looks like a biology and pharma oriented data-science environment that can search literature, connect to specialized databases, use institutional compute, generate analyses and visualizations, and draft research outputs. Several comments pointed out that this is not “science” in the broad sense and not even especially broad across STEM. Out of the box it appears centered on life sciences, with connectors for genomics, PubMed, FDA-related sources, and similar bioinformatics workflows, while researchers in physics, engineering, and earth science saw little for them yet.
The strongest positive read was about infrastructure, not model intelligence. People with domain experience said the painful part of computational biology is stitching together brittle databases, legacy interfaces, institutional clusters, and restricted research environments. On that front, Claude Science looks credible. Its architecture runs a local server with a browser UI, which several readers recognized as a good fit for Trusted Research Environments and pharma setups where data cannot leave a locked-down remote workspace but browser-based tools like
JupyterLab can still be exposed. That made the launch feel less like a flashy “AI scientist” claim and more like a serious attempt to fit inside real enterprise research constraints.
The dominant reaction was still distrust. Multiple hands-on reports said the product can produce useful first-pass work, especially for routine analysis and literature review, but it also hallucinates references, loses track of evidence, and can fabricate convincing-looking outputs. That made the product’s publication-oriented marketing land badly. The core objection was not that LLMs are useless for science. Plenty of people already use Claude or similar tools to write scripts, clean up ugly academic code, sanity-check ideas, and speed up exploratory analysis. The objection was that science already has a quality and reproducibility problem, and a tool that makes paper production easier than validation risks pouring fuel on it.
A few details softened that somewhat. One commenter highlighted the “standing reviewer agent,” which reportedly checks citations, traces numbers back to evidence, and flags figures that do not match the generating code. That feature was treated as one of the few genuinely differentiated pieces beyond a branded notebook shell plus connectors. Even so, readers who tested the product still reported bad citations and awkward failure modes, including safety systems tripping mid-session. The net view was pragmatic: there is clear value here for bioinformatics-style data work in secure organizations, and maybe later for wet-lab integration too, but nobody serious thinks this removes the need for expert review. If anything, it raises the bar for provenance, reproducibility, and disclosure.